[Key Financial Data](index=2&type=section&id=Item%20I.%20Key%20Financial%20Data) [Key Accounting Data and Financial Indicators](index=2&type=section&id=Item%20%28I%29.%20Key%20Accounting%20Data%20and%20Financial%20Indicators) In Q1 2024, the company's operating revenue slightly decreased by 2.25% year-on-year, but net loss attributable to shareholders significantly narrowed by 36.72%, improving from **-26.09 million RMB** in the prior year to **-16.51 million RMB**; net cash flow from operating activities increased by 98.95% year-on-year, indicating a substantial improvement in operational cash flow Q1 2024 Core Financial Indicators | Indicator | Current Period | Prior Period | YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue (RMB) | 351,661,269.16 | 359,755,333.96 | -2.25% | | Net Profit Attributable to Shareholders (RMB) | -16,511,232.42 | -26,093,463.01 | 36.72% | | Net Profit Attributable to Shareholders (Excluding Non-recurring Items) (RMB) | -23,096,003.61 | -26,675,304.63 | 13.42% | | Net Cash Flow from Operating Activities (RMB) | 39,777,116.95 | 19,993,535.68 | 98.95% | | Basic Earnings Per Share (RMB/share) | -0.0144 | -0.0227 | 36.56% | | Total Assets (RMB) | 3,811,353,366.63 | 3,944,651,719.01 (Prior Year-end) | -3.38% (vs. Beginning of Year) | | Total Equity Attributable to Shareholders (RMB) | 974,475,622.64 | 990,986,855.06 (Prior Year-end) | -1.67% (vs. Beginning of Year) | [Non-recurring Gains and Losses Items and Amounts](index=2&type=section&id=Item%20%28II%29.%20Non-recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) During the reporting period, the company's total non-recurring gains and losses amounted to **6.58 million RMB**, primarily from the reversal of impairment provisions for receivables totaling **5.14 million RMB** and government grants of **1.62 million RMB**, which positively contributed to the current period's net profit improvement Q1 2024 Non-recurring Gains and Losses Details | Item | Amount (RMB) | Description | | :--- | :--- | :--- | | Reversal of impairment provisions for receivables subject to separate impairment testing | 5,143,298.14 | Primarily due to the reversal of individually assessed impairment provisions for receivables | | Government grants recognized in current profit or loss | 1,615,103.77 | - | | Gains or losses on disposal of non-current assets | 233,360.93 | - | | Other non-operating income and expenses | 134,595.13 | - | | **Total** | **6,584,771.19** | - | [Analysis of Major Financial Indicator Changes](index=3&type=section&id=Item%20%28III%29.%20Analysis%20of%20Major%20Financial%20Indicator%20Changes) During the reporting period, several of the company's financial indicators showed significant changes; cash and cash equivalents substantially increased by **57.56%** due to increased collections, while other income grew by **172.32%** from higher government grants, and asset impairment losses turned positive due to the reversal of contract asset impairment provisions; net cash inflow from operating activities increased by **63%** due to the unfreezing of bank accounts, and net cash flow from financing activities improved by **49.92%** due to increased bank borrowings [Balance Sheet Item Changes](index=3&type=section&id=Item%201.%20Balance%20Sheet%20Items) Cash and cash equivalents at period-end significantly increased by **57.56%** from the beginning of the period, primarily due to increased collections, while notes receivable and notes payable grew by **85.16%** and **82.59%** respectively, reflecting increased bill settlement activities Major Balance Sheet Changes | Item | Period-end Balance (RMB) | Period-start Balance (RMB) | Change (%) | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Cash and cash equivalents | 113,828,617.36 | 72,243,108.74 | 57.56% | Primarily due to increased collections in the current period[9](index=9&type=chunk) | | Notes receivable | 12,921,463.75 | 6,978,442.65 | 85.16% | Primarily due to an increase in endorsed unexpired notes in the current period[9](index=9&type=chunk) | | Notes payable | 45,100,000.00 | 24,700,000.00 | 82.59% | Primarily due to an increase in bank acceptance bills issued in the current period[9](index=9&type=chunk) | [Income Statement Item Changes](index=3&type=section&id=Item%202.%20Income%20Statement%20Items) Sales expenses increased by **32.00%** due to higher litigation fees, while other income surged by **172.32%** from increased government grants; asset impairment losses turned positive, with a **-1088.43%** change, due to the reversal of impairment provisions for individually assessed contract assets, significantly impacting profit positively Major Income Statement Changes | Item | Current Period Amount (RMB) | Prior Period Amount (RMB) | Change (%) | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Sales expenses | 7,026,132.26 | 5,322,774.79 | 32.00% | Primarily due to increased litigation fees[11](index=11&type=chunk) | | Other income | 1,617,038.79 | 593,790.77 | 172.32% | Primarily due to increased government grants related to daily operations received in the current period[11](index=11&type=chunk) | | Asset impairment losses | 3,801,086.29 | -384,556.26 | -1088.43% | Primarily due to the collection of individually assessed contract assets and the corresponding reversal of impairment provisions[11](index=11&type=chunk) | | Gains on disposal of assets | 245,595.61 | 15,571.74 | 1477.19% | Primarily due to increased gains from disposal of fixed assets[11](index=11&type=chunk) | [Cash Flow Statement Item Changes](index=4&type=section&id=Item%203.%20Cash%20Flow%20Statement%20Items) Cash flow from operating activities saw 'cash received relating to other operating activities' increase by **63.00%** due to the unfreezing of bank accounts; net cash flow from financing activities improved by **49.92%** year-on-year, from a net outflow of **18.84 million RMB** to a net outflow of **9.43 million RMB**, driven by increased bank borrowings Major Cash Flow Statement Changes | Item | Current Period Amount (RMB) | Prior Period Amount (RMB) | Change (%) | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Cash received relating to other operating activities | 28,070,620.86 | 17,221,584.23 | 63.00% | Primarily due to the unfreezing of bank account funds[12](index=12&type=chunk) | | Cash received from borrowings | 29,200,000.00 | 17,990,000.00 | 62.31% | Primarily due to increased bank borrowings in the current period[12](index=12&type=chunk) | | Net cash flow from financing activities | -9,433,007.72 | -18,836,230.56 | 49.92% | Primarily due to increased bank borrowings in the current period[12](index=12&type=chunk) | [Shareholder Information](index=4&type=section&id=Item%20II.%20Shareholder%20Information) [Shareholder Ownership](index=4&type=section&id=Item%20%28I%29.%20Total%20Number%20of%20Common%20Shareholders%20and%20Preferred%20Shareholders%20with%20Restored%20Voting%20Rights%20and%20Top%20Ten%20Shareholders%27%20Holdings) As of the end of the reporting period, the company had **56,225** common shareholders; the top three shareholders, Feng Huoling, Zhang Hailin, and Sanya Daxing Group Co Ltd, collectively held over **30%** of the shares, with nearly all shares held by the second and third largest shareholders, Zhang Hailin and Sanya Daxing Group, being pledged and frozen, indicating certain equity risks - As of the end of the reporting period, the company had **56,225** common shareholders[14](index=14&type=chunk) Top Three Shareholders' Holdings and Pledged/Frozen Status | Shareholder Name | Holding Percentage (%) | Number of Shares Held | Number of Shares Pledged | Number of Shares Frozen | | :--- | :--- | :--- | :--- | :--- | | Feng Huoling | 11.29% | 129,510,000 | 25,924,000 | - | | Zhang Hailin | 10.78% | 123,660,000 | 123,660,000 | 123,660,000 | | Sanya Daxing Group Co Ltd | 8.29% | 95,132,742 | 95,130,000 | 95,132,742 | - Shareholders Feng Huoling, Zhang Hailin, and Zhang Yilin are parties acting in concert; Zhang Hailin and Zhang Yilin are brothers, and Feng Huoling is their brother-in-law; Sanya Daxing Group Co Ltd and Sanya Houde Investment Management Co Ltd are entities jointly controlled by Zhang Hailin and Zhang Yilin[15](index=15&type=chunk) [Other Significant Matters](index=5&type=section&id=Item%20III.%20Other%20Significant%20Matters) [Other Significant Matters](index=5&type=section&id=Item%20III.%20Other%20Significant%20Matters) During the reporting period, the company had no other significant matters requiring disclosure - The company had no other significant matters to explain during the reporting period[16](index=16&type=chunk) [Quarterly Financial Statements](index=6&type=section&id=Item%20IV.%20Quarterly%20Financial%20Statements) [Financial Statements](index=6&type=section&id=Item%20%28I%29.%20Financial%20Statements) As of March 31, 2024, the company's total assets were **3.811 billion RMB**, and total liabilities were **2.858 billion RMB**; Q1 2024 operating revenue reached **352 million RMB**, with a net loss of **15.36 million RMB**, of which **16.51 million RMB** was attributable to owners of the parent company, while net cash flow from operating activities was a strong **39.78 million RMB** [Consolidated Balance Sheet](index=6&type=section&id=Item%201.%20Consolidated%20Balance%20Sheet) As of March 31, 2024, the company's total assets were **3.811 billion RMB**, a **3.38%** decrease from the beginning of the year; total liabilities were **2.858 billion RMB**, down **3.96%** from the beginning of the year; and total equity attributable to owners of the parent company was **974 million RMB**, a **1.67%** decrease from the beginning of the year Key Consolidated Balance Sheet Items | Item | Period-end Balance (RMB) | Period-start Balance (RMB) | | :--- | :--- | :--- | | Total Assets | 3,811,353,366.63 | 3,944,651,719.01 | | Total Liabilities | 2,858,038,649.87 | 2,975,973,916.41 | | Total Equity Attributable to Owners of the Parent Company | 974,475,622.64 | 990,986,855.06 | | Total Equity | 953,314,716.76 | 968,677,802.60 | [Consolidated Income Statement](index=8&type=section&id=Item%202.%20Consolidated%20Income%20Statement) In Q1 2024, the company's total operating revenue was **352 million RMB**, a **2.25%** year-on-year decrease, while total operating costs were **367 million RMB**, down **2.28%** year-on-year; net profit was **-15.36 million RMB**, a significant narrowing of loss from **-24.66 million RMB** in the prior year, with net profit attributable to owners of the parent company at **-16.51 million RMB**, also better than **-26.09 million RMB** in the prior year Key Consolidated Income Statement Items | Item | Current Period Amount (RMB) | Prior Period Amount (RMB) | | :--- | :--- | :--- | | I. Total Operating Revenue | 351,661,269.16 | 359,755,333.96 | | II. Total Operating Costs | 367,200,618.19 | 375,764,961.86 | | III. Operating Profit | -10,938,125.37 | -21,881,164.10 | | IV. Total Profit | -10,836,210.25 | -21,904,884.09 | | V. Net Profit | -15,363,085.84 | -24,664,212.11 | | Net Profit Attributable to Owners of the Parent Company | -16,511,232.42 | -26,093,463.01 | [Consolidated Cash Flow Statement](index=10&type=section&id=Item%203.%20Consolidated%20Cash%20Flow%20Statement) During the reporting period, net cash flow from operating activities was **39.78 million RMB**, a **98.95%** increase from **19.99 million RMB** in the prior year, primarily due to increased sales collections; net cash flow from investing activities was **-5.54 million RMB**, and net cash flow from financing activities was **-9.43 million RMB**; cash and cash equivalents at period-end totaled **57.18 million RMB** Key Consolidated Cash Flow Statement Items | Item | Current Period Amount (RMB) | Prior Period Amount (RMB) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 39,777,116.95 | 19,993,535.68 | | Net Cash Flow from Investing Activities | -5,540,836.94 | -7,906,562.78 | | Net Cash Flow from Financing Activities | -9,433,007.72 | -18,836,230.56 | | Net Increase in Cash and Cash Equivalents | 24,803,272.29 | -6,749,257.66 | | Cash and Cash Equivalents at Period-end | 57,175,677.72 | 85,571,100.13 | [Audit Report](index=12&type=section&id=Item%20%28III%29.%20Audit%20Report) The company's Q1 2024 report is unaudited - The company's first-quarter report is unaudited[26](index=26&type=chunk)

海南瑞泽新型建材股份有限公司 董事会审计委员会关于公司计提资产减值准备合理性的说明 公司 2023 年度结合资产及经营的实际情况计提减值准备，计提的依据充分 合理，符合会计谨慎性原则。本次计提资产减值准备后，财务报表能够更加公允 地反映公司的财务状况、资产价值及经营成果，有助于提供更加真实、可靠、准 确的会计信息。因此，我们同意公司本次计提资产减值准备事项并同意提交董事 会审议批准。 海南瑞泽新型建材股份有限公司 董事会审计委员会 2024 年 4 月 18 日 根据《深圳证券交易所股票上市规则》《企业会计准则第 8 号—资产减值》 《公司章程》等相关文件规定，我们作为海南瑞泽新型建材股份有限公司（以下 简称"公司"）董事会审计委员会委员，通过对公司本次计提资产减值准备相关 材料的认真审查，我们对公司 2023 年度计提资产减值准备合理性说明如下： ...

海南瑞泽新型建材股份有限公司 2023 年度监事会工作报告 | | | 《关于公司续聘会计师事务所的议案》 | | --- | --- | --- | | 2023.4.27 | 第五届监事 会第十八次 | 《关于公司<2023 年第一季度报告>的议案》 | | | 会议 | | | 2023.8.29 | 第五届监事 | 《关于公司 2023 年半年度报告及摘要的议案》 | | | 会第十九次 会议 | 《关于公司 2023 年半年度计提资产减值准备的议案》 | | | | 《关于注销 年股票期权激励计划部分股票期权的议案》 2021 | | 2023.10.30 | 第五届监事 会第二十次 | 《关于公司<2023 年第三季度报告>的议案》 | | | 会议 | | 上述会议决议公告详见公司披露于《证券时报》《证券日报》《上海证券报》 《中国证券报》以及巨潮资讯网（www.cninfo.com.cn）上的相关信息。 2023 年度，监事会未有单独聘请会计师事务所、律师事务所等专业机构协 助工作的情形，也未有单独提议召开股东大会的情形。 二、监事会对公司 2023 年度有关事项的审核意见 2023 年度，海 ...

证券代码：002596 证券简称：海南瑞泽 公告编号：2024-021 海南瑞泽新型建材股份有限公司 关于2024年度日常关联交易预计的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、2024 年度预计日常关联交易基本情况 （一）预计关联交易概述 | | | 根据项目公 司章程约 | | | | | --- | --- | --- | --- | --- | --- | | 河北雄安寨里混凝 | | 定，公司对 | | | | | 土有限公司 | 分红权 | 其实现利润 | 1,500 | 51.12 | - | | | | 部分享有 | | | | | | | 28%的分红 | | | | | | | 权 | | | | | 小计 | - | - | 2,002.30 | 181.47 | 344.75 | | 合计 | - | - | 10,287.30 | 1,073.80 | 7,030.05 | 本次预计关联交易为海南瑞泽新型建材股份有限公司（以下简称"公司"） 及子公司与关联方之间因向关联人提供运营服务、车辆租赁、劳务服务以及租赁 服务， ...

海南瑞泽新型建材股份有限公司 出具与持续经营相关的重大不确定性段落的无保留 意见涉及事项影响已消除的审核报告 众环专字[2024]1700035 号 一、 董事会的责任 出具与持续经营相关的重大不确定性段落的无保留意见 众环专字[2024]1700035 号 海南瑞泽新型建材股份有限公司全体股东： 我们接受委托，审核了后附的海南瑞泽新型建材股份有限公司（以下简称"海 南瑞泽"）编制的《关于 2022 年度审计报告与持续经营相关的重大不确定性段落 的无保留意见涉及事项影响已消除的专项说明》。 涉及事项影响已消除的审核报告 海南瑞泽董事会按照《深圳证券交易所股票上市规则》的要求编制《关于 2022 年度审计报告与持续经营相关的重大不确定性段落的无保留意见涉及事项 影响已消除的专项说明》，保证其内容真实、准确、完整，不存在虚假记录、误 导性陈述或重大遗漏是海南瑞泽董事会的责任。 二、 注册会计师的责任 我们的责任是在实施审核工作的基础上对海南瑞泽董事会编制的《关于 2022 年度审计报告与持续经营相关的重大不确定性段落的无保留意见涉及事项影响 已消除的专项说明》发表审核意见。我们按照《中国注册会计师其他鉴证业务准 ...

海南瑞泽新型建材股份有限公司 审计报告 众环审字[2024]1700043 号 审计报告 众环审字[2024]1700043 号 海南瑞泽新型建材股份有限公司全体股东： 一、 审计意见 我们审计了海南瑞泽新型建材股份有限公司（以下简称"海南瑞泽"或"公 司"）财务报表，包括 2023 年 12 月 31 日的合并及公司资产负债表，2023 年度的 合并及公司利润表、合并及公司现金流量表、合并及公司股东权益变动表以及相 关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制， 公允反映了海南瑞泽 2023 年 12 月 31 日合并及公司的财务状况以及 2023 年度合 并及公司的经营成果和现金流量。 二、 形成审计意见的基础 我们按照中国注册会计师审计准则的规定执行了审计工作。审计报告的"注 册会计师对财务报表审计的责任"部分进一步阐述了我们在这些准则下的责任。 按照中国注册会计师职业道德守则，我们独立于海南瑞泽，并履行了职业道德方 面的其他责任。我们相信，我们获取的审计证据是充分、适当的，为发表审计意 见提供了基础。 三、 关键审计事项 关键审计事项是我们根据职业判断，认为对本期 ...

海南瑞泽新型建材股份有限公司 内部控制审计报告 众环审字[2024]1700044 号 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其 有效性，并如实披露内部控制评价报告是公司董事会的责任。监事会对董事会建 立和实施内部控制进行监督。经理层负责组织领导企业内部控制的日常运行。公 司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存在任何虚假 记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个 别及连带法律责任。 海南瑞泽新型建材股份有限公司 2023 年度内部控制自我评价报告 海南瑞泽新型建材股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要 求（以下简称"企业内部控制规范体系"），结合海南瑞泽新型建材股份有限公 司（以下简称"公司"）内部控制制度和评价办法，在内部控制日常监督和专项 监督的基础上，公司对2023年12月31日（内部控制评价报告基准日）的内部控制 有效性进行了评价。 一、重要声明 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及 相关信息真实完整，提高经营效率和效果，促进实现发展战略。由于 ...

海南瑞泽新型建材股份有限公司 关于 2023 年度会计师事务所履职情况的评估报告 海南瑞泽新型建材股份有限公司（以下简称"公司"）聘请中审众环会计师事 务所（特殊普通合伙）（以下简称"中审众环"）作为公司 2023 年度财务报告审 计机构及内部控制审计机构。根据财政部、国资委及证监会颁布的《国有企业、 上市公司选聘会计师事务所管理办法》等要求，公司对中审众环 2023 年度审计 过程中的履职情况进行评估。经评估，公司认为，中审众环在资质等方面合规有 效，履职能够保持独立性，勤勉尽责，公允表达意见。具体情况如下： 一、基本情况 （一）会计师事务所基本情况 中审众环始创于 1987 年，是全国首批取得国家批准具有从事证券、期货相 关业务资格及金融业务审计资格的大型会计师事务所之一。根据财政部、证监会 发布的从事证券服务业务会计师事务所备案名单，中审众环具备股份有限公司发 行股份、债券审计机构的资格。2013 年 11 月，按照国家财政部等有关要求转制 为特殊普通合伙制。 截至 2023 年 12 月 31 日，中审众环合伙人数量 216 人、注册会计师数量 1,244 人、签署过证券服务业务审计报告的注册会计师人 ...

证券代码：002596 证券简称：海南瑞泽 公告编号：2024-020 三、董事会意见 公司结合现阶段的经营状况、现金流量状况、资金需求及未来发展等因素， 制定了 2023 年度利润分配预案，本次利润分配预案符合公司实际情况，有利于 公司的持续稳定和健康发展。公司拟定的利润分配预案合法、合规，符合《上市 公司监管指引第 3 号——上市公司现金分红》《公司章程》以及《公司利润分配 管理制度》等相关规定，不存在损害公司及全体股东尤其中小股东利益的情形。 四、监事会意见 海南瑞泽新型建材股份有限公司 关于 2023 年度拟不进行利润分配的专项说明公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 海南瑞泽新型建材股份有限公司（以下简称"公司"）于 2024 年 4 月 18 日 召开第五届董事会第三十九次会议、第五届监事会第二十二次会议，审议通过了 《关于公司 2023 年度利润分配预案的议案》，现将相关情况公告如下： 一、公司 2023 年度利润分配预案 经中审众环会计师事务所（特殊普通合伙）审计，公司 2023 年度实现归属 于上市公司股东的净利润-506,8 ...

落的无保留意见涉及事项影响已消除的专项说明 中审众环会计师事务所（特殊普通合伙）对海南瑞泽新型建材股份有限公司 （以下简称"公司"或"海南瑞泽"）2022 年度财务报表出具了与持续经营相关 的重大不确定性段落的无保留意见的审计报告（众环审字[2023]1700005 号）。 公司董事会现就 2022 年度审计报告中与持续经营相关的重大不确定性段落的无 保留意见所涉事项的影响已消除说明如下： 一、2022 年度审计报告中与持续经营相关的重大不确定性段落的无保留意 见所涉及的内容 "与持续经营相关的重大不确定性" 我们提醒财务报表使用者关注，如财务报表附注二、2 及六、32 所述，截止 2022 年 12 月 31 日，海南瑞泽有息债务合计 149,026.41 万元，其中短期借款 8,490.00 万元、长期借款 114,752.58 万元、长期应付款 1,040.18 万元、一年内到 期的非流动负债 20,577.22 万元、其他有息负债 4,166.43 万元，海南瑞泽为下属 公司 PPP 项目、苗木项目的借款等提供了担保。截止 2022 年 12 月 31 日，PPP 项目有 2,770.00 万元借款本 ...